Dengue haemorrhagic fever: a job done via exosomes?

被引:37
作者
Mishra, Ritu [1 ]
Lata, Sneh [1 ]
Ali, Amjad [2 ]
Banerjea, Akhil C. [1 ]
机构
[1] Natl Inst Immunol, Virol Lab, Aruna Asaf Ali Marg, New Delhi 110067, India
[2] Jamia Millia Islamia, New Delhi, India
关键词
Dengue virus; dengue haemorrhagic fever; microRNA; exosomes; hyperpermeability; ORIGINAL ANTIGENIC SIN; T-CELL RESPONSES; VIRUS-INFECTION; PLASMA LEAKAGE; IMMUNE ACTIVATION; DISEASE SEVERITY; VE-CADHERIN; PATHOGENESIS; PERMEABILITY; MECHANISM;
D O I
10.1080/22221751.2019.1685913
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Dengue fever is one of those unique diseases where host immune responses largely determine the pathogenesis and its severity. Earlier studies have established the fact that dengue virus (DENV) infection causes haemorrhagic fever and shock syndrome, but it is not directly responsible for exhibiting these clinical symptoms. It is noteworthy that clinically, vascular leakage syndrome does not develop for several days after infection despite a robust innate immune response that elicits the production of proinflammatory and proangiogenic cytokines. The onset of hyperpermeability in severe cases of dengue disease takes place around the time of defervescence and after clearance of viraemia. Extracellular vesicles are known to carry biological information (mRNA, miRNA, transcription factors) from their cells of origin and have emerged as a significant vehicle for horizontal transfer of stress signals. In dengue virus infection, the relevance of exosomes can be instrumental since the majority of the immune responses in severe dengue involve heavy secretion and circulation of pro-inflammatory cytokines and chemokines. Here, we present an updated review which will address the unique and puzzling features of hyperpermeability associated with DENV infection with a special focus on the role of secreted extracellular vesicles.
引用
收藏
页码:1626 / 1635
页数:10
相关论文
共 85 条
[31]   The expression profile of human peripheral blood mononuclear cell miRNA is altered by antibody-dependent enhancement of infection with dengue virus serotype 3 [J].
Jiang, Liming ;
Sun, Qiangming .
VIROLOGY JOURNAL, 2018, 15
[32]   Role of RNA Interference (RNAi) in Dengue Virus Replication and Identification of NS4B as an RNAi Suppressor [J].
Kakumani, Pavan Kumar ;
Ponia, Sanket Singh ;
Rajgokul, K. S. ;
Sood, Vikas ;
Chinnappan, Mahendran ;
Banerjea, Akhil C. ;
Medigeshi, Guruprasad R. ;
Malhotra, Pawan ;
Mukherjee, Sunil K. ;
Bhatnagar, Raj K. .
JOURNAL OF VIROLOGY, 2013, 87 (16) :8870-8883
[33]  
KOURI GP, 1989, B WORLD HEALTH ORGAN, V67, P375
[34]   Extracellular Vesicles Including Exosomes Regulate Innate Immune Responses to Hepatitis B Virus Infection [J].
Kouwaki, Takahisa ;
Fukushima, Yoshimi ;
Daito, Takuji ;
Sanada, Takahiro ;
Yamamoto, Naoki ;
Mifsud, Edin J. ;
Leong, Chean Ring ;
Tsukiyama-Kohara, Kyoko ;
Kohara, Michinori ;
Matsumoto, Misako ;
Seya, Tsukasa ;
Oshiumi, Hiroyuki .
FRONTIERS IN IMMUNOLOGY, 2016, 7
[35]   Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes [J].
Kowal, Joanna ;
Arras, Guillaume ;
Colombo, Marina ;
Jouve, Mabel ;
Morath, Jakob Paul ;
Primdal-Bengtson, Bjarke ;
Dingli, Florent ;
Loew, Damarys ;
Tkach, Mercedes ;
Thery, Clotilde .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (08) :E968-E977
[36]   miR-130a and miR-212 Disrupt the Intestinal Epithelial Barrier through Modulation of PPARγ and Occludin Expression in Chronic Simian Immunodeficiency Virus-Infected Rhesus Macaques [J].
Kumar, Vinay ;
Mansfield, Joshua ;
Fan, Rong ;
MacLean, Andrew ;
Li, Jian ;
Mohan, Mahesh .
JOURNAL OF IMMUNOLOGY, 2018, 200 (08) :2677-2689
[37]   ACTIVATION OF LYMPHOCYTES-T IN DENGUE VIRUS-INFECTIONS - HIGH-LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTOR, SOLUBLE CD4, SOLUBLE CD8, INTERLEUKIN-2, AND INTERFERON-GAMMA IN SERA OF CHILDREN WITH DENGUE [J].
KURANE, I ;
INNIS, BL ;
NIMMANNITYA, S ;
NISALAK, A ;
MEAGER, A ;
JANUS, J ;
ENNIS, FA .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (05) :1473-1480
[38]   Dengue virus (DV) enhancing antibody activity in preillness plasma does not predict subsequent disease severity or viremia in secondary DV infection [J].
Laoprasopwattana, K ;
Libraty, DH ;
Endy, TP ;
Nisalak, A ;
Chunsuttiwat, S ;
Vaughn, DW ;
Reed, G ;
Ennis, FA ;
Rothman, AL ;
Green, S .
JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (03) :510-519
[39]  
Lardo S, 2018, ACTA MED INDONES, V50, P70
[40]   Current management of severe dengue infection [J].
Lee, Tau Hong ;
Lee, Linda Kay ;
Lye, David Chien ;
Leo, Yee Sin .
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2017, 15 (01) :67-78